Home›Search›Current Signal Transduction Therapy

Current Signal Transduction Therapy

Bentham Science Publishers · United Arab Emirates · Est. 1969

ISSN1574-3624

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.149

H-Indexi

SNIPi

0.192

Total Worksi

600

Total Citationsi

2,770

2yr Mean Citednessi

0.48

Open Impact Factor alternative

Aims & Scope

Subject areas: Endocrinology; Pharmacology (medical).

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published1969

Annual Volume~ 21 articles / year

StatusActive (last: 2026)

Total Publications600

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1574-3624

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

143

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

EndocrinologyQ4

Pharmacology (medical)Q4

Subject Classification

Scopus Categories

Pharmacology (medical)Endocrinology

Research Topics (OpenAlex)

Diverse Scientific and Economic StudiesCancer, Hypoxia, and MetabolismMicroRNA in disease regulationCancer Mechanisms and TherapyComputational Drug Discovery MethodsCancer Treatment and Pharmacology14-3-3 protein interactionsHuman auditory perception and evaluationSynthesis and biological activityCytokine Signaling Pathways and Interactions

Frequently asked questions about Current Signal Transduction Therapy

Is Current Signal Transduction Therapy a predatory journal?

PubScope has no integrity flags on record for Current Signal Transduction Therapy: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Current Signal Transduction Therapy?

Current Signal Transduction Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.149.

Is Current Signal Transduction Therapy indexed in Scopus and Web of Science?

Current Signal Transduction Therapy is indexed in Scopus.

What is the aims and scope of Current Signal Transduction Therapy?